Page 168 - Quantitative Imaging of Small Tumours with Positron Emission Tomography

Systematic review and meta-analysis 21. Avril N, Bense S, Ziegler SI, et al. Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med. 1997;38:1186-1191. 22. Tsujikawa T, Otsuka H, Morita N, et al. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma? Ann Nucl Med. 2008;22:23-30. 23. Cremerius U, Fabry U, Neuerburg J, Zimny M, Osieka R, Buell U. Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Nucl Med Commun. 1998;19:1055-1063. 24. Tsujikawa T, Tsuchida T, Imamura Y, et al. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011;36:661-664. 25. Vesselle H, Turcotte E, Wiens L, et al. Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis. Clin Cancer Res. 2004;10:4709-4716. 26. Rousseau C, Devillers A, Campone M, et al. FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients. Eur J Nucl Med Mol Imaging. 2011;38:1029-1036. 27. Fayad H, Le Pogam A, Lamare F, et al. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT. Q J Nucl Med Mol Imaging. 2014;58:319-328. 28. Sakaguchi Y, Mizoguchi N, Mitsumoto T, et al. A simple table lookup method for PET/CT partial volume correction using a point-spread function in diagnosing lymph node metastasis. Ann Nucl Med. 2010;24:585-591. 29. Wang YW, Wu CS, Chang CH, et al. Partial volume correction for equivocal retropharyngeal nodal metastases of nasopharyngeal carcinoma with fluorodeoxyglucose positron emission tomography- computed tomography. Journal of Medical and Biological Engineering. 2015;35:218-225. 30. Mathieu C, Ferrer L, Carlier T, et al. Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer. Front Med (Lausanne). 2015;2:67. 31. Lasnon C, Hicks RJ, Beauregard JM, et al. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer. Clin Nucl Med. 2012;37:971- 7 976. 32. Bellevre D, Blanc Fournier C, Switsers O, et al. Staging the axilla in breast cancer patients with (1) (8)F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems? Eur J Nucl Med Mol Imaging. 2014;41:1103-1112. 33. Kawashima K, Kato K, Tomabechi M, et al. Clinical evaluation of F-fluorodeoxyglucose-positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer. Br J Radiol. 2016:20150938. 34. Ozawa Y, Hara M, Shibamoto Y, Tamaki T, Nishio M, Omi K. Utility of high-definition FDG-PET image reconstruction for lung cancer staging. Acta Radiol. 2013;54:916-920. 35. Um SW, Kim H, Koh WJ, et al. Prognostic Value of F-18-FDG Uptake on Positron Emission Tomography in Patients with Pathologic Stage I Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2009;4:1331-1336. 36. Ohtaka K, Hida Y, Kaga K, et al. Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction. Anticancer Res. 2013;33:5193- 5198. 37. van Heijl M, Omloo JM, van Berge Henegouwen MI, van Lanschot JJ, Sloof GW, Boellaard R. Influence of ROI definition, partial volume correction and SUV normalization on SUV-survival correlation in oesophageal cancer. Nucl Med Commun. 2010;31:652-658. 38. Hatt M, Le Pogam A, Visvikis D, Pradier O, Cheze Le Rest C. Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer. J Nucl Med. 2012;53:12-20. 39. Gallivanone F, Canevari C, Gianolli L, et al. A partial volume effect correction tailored for 18F-FDG- PET oncological studies. Biomed Res Int. 2013;2013:780458. 40. Picchio M, Kirienko M, Mapelli P, et al. Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:21-31. 167